GLP1R and hydrops fetalis: Compared with placebo, in the additive NMA, the triple combination of MRA, SGLT2i, and GLP-1 RA was associated with a 73% reduction in the risk of HF hospitalization (0.27 [0.18–0.42]; ARR 6.2% [4.2%–7.5%]; NNT 16 [13–24]; Fig. 4B).